BioNexus Gene Lab (BGLC) vs Burning Rock Biotech (BNR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Burning Rock Biotech is the larger company by market cap ($163.4 million vs $3.8 million), about 43.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGLC | BNR |
|---|---|---|
| Share price | $1.29 | $15.49 |
| Market cap | $3.78M | $163.36M |
| 1-day change | -2.70% | +3.27% |
| YTD return | — | -23.13% |
| 1-year return | — | +80.54% |
| 5-year return | — | -89.21% |
| EPS (TTM) | $-1.26 | $-0.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.89 | $41.72 |
| 52-week low | $1.07 | $6.79 |
| Distance from 52-week high | -78.09% | -62.87% |
| Average volume | 11.04K | 28.59K |
| Shares outstanding | 2.93M | 8.81M |
| Employees | 19 | 667 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Burning Rock Biotech is about 43.2 times larger than BioNexus Gene Lab by market value ($163.36M vs $3.78M).
About BioNexus Gene Lab
BGLC stock →BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.
Health Care · Medical Specialities · 19 employees
About Burning Rock Biotech
BNR stock →Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Health Care · Medical Specialities · 667 employees
BGLC vs BNR FAQ
Which is bigger, BioNexus Gene Lab or Burning Rock Biotech?
Burning Rock Biotech (BNR) is larger, with a market capitalization of $163.36M compared with $3.78M for BioNexus Gene Lab (BGLC).
Are BioNexus Gene Lab and Burning Rock Biotech in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.